Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 21, 2023
Expands Access to BD HPV Test that More Precisely Identifies Patients' Risk for Cervical Cancer FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX),...
-
Feb 15, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the company has been named to America's Best Large Employers List 2023 by Forbes,...
-
Feb 8, 2023
Single Test on BD MAX™ Molecular Diagnostic System Identifies and Differentiates Multiple Respiratory Infectious Diseases FRANKLIN LAKES, N.J., Feb. 8, 2023 /PRNewswire/ -- BD (Becton, Dickinson...
-
Feb 3, 2023
New BD Rhapsody™ HT Xpress System and Other Innovations to be Unveiled at AGBT, Enhancing an End-To-End Single-Cell Multiomics Offering FRANKLIN LAKES, N.J., Feb. 3, 2023 /PRNewswire/ -- BD...
-
Feb 2, 2023
Execution of BD 2025 Strategy Delivering Consistent and Durable Performance Revenue of $4.6 billion decreased 2.8% as reported and increased 1.7% on a currency-neutral basis Revenue from base...
-
Jan 31, 2023
Company's Ongoing Commitment to Advance Workplace Equality Shows Progress in Female Leadership and Talent Pipeline FRANKLIN LAKES, N.J., Jan. 31, 2023 /PRNewswire/ -- BD (Becton, Dickinson and...
-
Jan 25, 2023
Highlights Critical Importance of Transparency and Collaboration FRANKLIN LAKES, N.J., Jan. 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...
-
Jan 24, 2023
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on March 31, 2023 to holders of record on March 10,...
-
Jan 11, 2023
The 3rd Generation BD Kiestra™ Total Lab Automation System Offers Flexible Instrument to Optimize Lab Space and Streamline Workflow FRANKLIN LAKES, N.J., Jan. 11, 2023 /PRNewswire/ -- BD...
-
Jan 9, 2023
Assay for Research and Clinical Use Now Globally Available for the BD MAX™ System FRANKLIN LAKES, N.J., Jan. 9, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...
-
Jan 6, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday,...
-
Jan 6, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michelle Quinn has been named acting general counsel of BD, succeeding Samrat...
-
Jan 5, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2023 on...
-
Jan 5, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released findings from a survey conducted by The Harris Poll, between Nov. 14-16, 2022, among 872...
-
Dec 20, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday,...
-
Dec 8, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its second annual Global Inclusion, Diversity and Equity (ID&E) Report...
-
Dec 7, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named among the top 25% of Newsweek's list of America's Most Responsible...
-
Nov 30, 2022Facility Will Add 500 New Jobs Over the Next Two Years
TIJUANA, Baja California, Mexico (Nov. 30, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was joined by government officials from...
-
Nov 15, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on...
-
Nov 10, 2022
Execution of BD 2025 Strategy Driving Consistent Durable Growth Q4 revenue from continuing operations of $4.8 billion decreased 1.8% as reported and increased 2.3% on a currency-neutral basis Q4...
-
Nov 10, 2022
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, an increase of 4.6% from the previous quarter. The dividend...
-
Nov 2, 2022
Ridgewood, NJ, November 2, 2022 – Valley-Mount Sinai Comprehensive Cancer Care is pleased to be the recipient of a $652,000 grant over three years from BD (Becton, Dickinson and Company), a...
-
Oct 26, 2022Conforms to Independently Audited International Standards for Information Security: ISO/IEC 27001:2022
FRANKLIN LAKES, N.J. (Oct. 26, 2022) – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced its enterprise-level Information Security Management...
-
Oct 18, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today announced a co-exclusive commercial agreement aimed at...
-
Oct 17, 2022BD, Biocorp Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable DrugsCompanies to Explore Opportunities to Integrate Biocorp’s Injay® Technology with BD UltraSafePlus™ Passive Needle Guard to Help Biopharmaceutical Manufacturers Capture and Transmit Self-Administered Injection Data.
FRANKLIN LAKES, N.J. (October 17, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biocorp, a medical device and delivery systems...